Skip to main content

Local Bounti CorporationDE

For the period ended Mar 31, 2024. Filed May 10, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 10, 2024

LOCL$0.78-2.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Part I – FI

PART I - FINANCIAL INFORMATION

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

March 31,December 31,
20242023
Assets
Current assets
Cash and cash equivalents$8,242$10,326
Restricted cash6,4896,569
Accounts receivable, net3,3603,078
Inventory, net4,9604,210
Prepaid expenses and other current assets2,6202,805
Total current assets25,67126,988
Property and equipment, net344,112313,166
Operating lease right-of-use assets155172
Intangible assets, net40,46141,353
Other assets3,00873
Total assets$413,407$381,752
Liabilities and stockholders' equity
Current liabilities
Accounts payable$12,778$14,640
Accrued liabilities19,31417,204
Financing obligation25—
Operating lease liabilities7697
Total current liabilities32,19331,941
Long-term debt, net of debt issuance costs329,775277,985
Financing obligation, noncurrent49,39749,225
Operating lease liabilities, noncurrent95114
Warrant liability11,3947,214
Total liabilities422,854366,479
Commitments and contingencies (Note 10)
Stockholders' (deficit) equity
Common stock, 0.0001 par value, 400,000,000 shares authorized, 8,437,542 and 8,311,229 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively11
Additional paid-in capital317,930318,600
Accumulated deficit(327,378)(303,328)
Total stockholders' (deficit) equity(9,447)15,273
Total liabilities and stockholders' equity$413,407$381,752

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

Three Months Ended March 31,
20242023
Sales$8,383$6,698
Cost of goods sold(1)(2)7,5976,419
Gross profit786279
Operating expenses:
Research and development(1)(2)3,4873,576
Selling, general and administrative(1)(2)7,59815,981
Total operating expenses11,08519,557
Loss from operations(10,299)(19,278)
Other income (expense):
Change in fair value of warrant liability(4,180)—
Interest expense, net(9,608)(4,299)
Other income3750
Net loss$(24,050)$(23,527)
Net loss applicable to common stockholders per basic common share:
Basic and diluted$(2.89)$(3.04)
Weighted average common shares outstanding:
Basic and diluted8,325,9447,727,866

(1)Amounts include stock-based compensation as follows:

Three Months Ended March 31,
20242023
Cost of goods sold$21$87
Research and development93738
Selling, general and administrative(1,048)5,134
Total stock-based compensation expense, net of amounts capitalized$(934)$5,959

(2)Amounts include depreciation and amortization as follows:

Three Months Ended March 31,
20242023
Cost of goods sold$1,203$936
Research and development797566
Selling, general and administrative1,2281,956
Total depreciation and amortization$3,228$3,458

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY

FOR THE THREE MONTHS ENDED MARCH 31, 2024 and 2023

(in thousands, except share data)

Common Stock · AdditionalPaid-inCapital · AccumulatedDeficit · Total Stockholders'(Deficit) Equity
Shares · Amount
Balance, December 31, 20238,311,237$1$318,600$(303,328)$15,273
Vesting of restricted stock units, net126,305————
Stock-based compensation——(670)—(670)
Net loss———(24,050)(24,050)
Balance, March 31, 20248,437,542$1$317,930$(327,378)$(9,447)
Common Stock · AdditionalPaid-inCapital · AccumulatedDeficit · Total Stockholders'Equity
Shares · Amount
Balance, December 31, 20227,976,980$1$300,645$(179,313)$121,333
Vesting of restricted stock units, net41,502————
Stock-based compensation——6,361—6,361
Net loss———(23,527)(23,527)
Balance, March 31, 20238,018,482$1$307,006$(202,840)$104,167

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Three Months EndedMarch 31,
20242023
Operating Activities:
Net loss$(24,050)$(23,527)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation2,3351,782
Amortization of intangible assets8931,676
Stock-based compensation expense, net of amounts capitalized(934)5,959
Allowance for expected credit losses—8
Inventory allowance22330
Loss on disposal of property and equipment3—
Change in fair value of warrant liability4,180—
Paid-in-kind interest expense9,786—
Amortization of debt issuance costs2,100981
Interest expense on financing obligation19850
Changes in operating assets and liabilities:
Accounts receivable(281)76
Inventory(973)(284)
Prepaid expenses and other current assets1814
Other assets(2,936)—
Accounts payable969571
Operating lease liabilities(21)—
Accrued liabilities1,2444,844
Net cash used in operating activities(7,083)(7,830)
Investing Activities:
Purchases of property and equipment(34,985)(32,685)
Net cash used in investing activities(34,985)(32,685)
Financing Activities:
Proceeds from issuance of debt39,90423,045
Net cash provided by financing activities39,90423,045
Net decrease in cash and cash equivalents and restricted cash(2,164)(17,470)
Cash and cash equivalents and restricted cash at beginning of period16,89524,938
Cash and cash equivalents and restricted cash at end of period$14,731$7,468

Reconciliation of cash, cash equivalents, and restricted cash from the Unaudited Condensed Consolidated Balance Sheets to the Unaudited Condensed Consolidated Statements of Cash Flows

Cash and cash equivalents$8,242$7,468
Restricted cash6,489—
Total cash and cash equivalents and restricted cash as shown in the Unaudited Condensed Consolidated Statements of Cash Flows$14,731$7,468
Non-cash activities:
Warrants issued in connection with debt modification$—$25,697
Purchases of property and equipment included in accounts payable and accrued liabilities$1,965$7,584
Interest capitalized to property and equipment, net$5,683$2,079
Stock-based compensation capitalized to property and equipment, net$264$577
Non-cash equity settlement on employee receivable$—$175

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

  1. Business Description

Description of the Business

Local Bounti Corporation ("Local Bounti" or the "Company") was founded in August 2018 and is headquartered in Hamilton, Montana. The Company is a producer of sustainably grown living lettuce, and loose leaf lettuce. The Company is a controlled environment agriculture ("CEA") company that utilizes patented Stack & Flow Technology®, which is a hybrid of vertical and hydroponic greenhouse farming, to grow healthy food sustainably and affordably. Through the Company's CEA process, its goal is to produce environmentally sustainable products in a manner that will increase harvest efficiency, limit water usage, and reduce the carbon footprint of the production and distribution process.

  1. Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

Management of Local Bounti is responsible for the Unaudited Condensed Consolidated Financial Statements included in this document, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in the statements herein.

The Unaudited Condensed Consolidated Financial Statements do not include all of the disclosures required by GAAP for annual financial statements and should be read in conjunction with the audited Consolidated Financial Statements of the Company for the year ended December 31, 2023 (the "Annual Financial Statements") as filed with the SEC. In the opinion of the Company, the accompanying Unaudited Condensed Financial Statements contain all adjustments, consisting of only normal recurring adjustments, necessary to fairly present its financial position as of March 31, 2024, its results of operations for the three months ended March 31, 2024 and 2023, its cash flows for the three months ended March 31, 2024 and 2023, and its stockholders' (deficit) equity for the three months ended March 31, 2024 and 2023. Results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year ending December 31, 2024 or any future period. The Unaudited Condensed Consolidated Balance Sheet at December 31, 2023 was derived from the Annual Financial Statements but does not contain all of the footnote disclosures from the Annual Financial Statements.

Liquidity

The Company has incurred losses and generated negative cash flows from operations since its inception. At March 31, 2024, the Company had an accumulated deficit of $327.4 million and cash and cash equivalents and restricted cash of $14.7 million.

The Ninth Amendment to the credit facilities with Cargill Financial, as described in Note 6, Debt, allows for the payment in kind of the quarterly interest payments due and payable for the quarters ending June 30, 2024, September 30, 2024, and December 31, 2024. The Ninth Amendment also provides for up to $15.0 million in working capital for the Company, $5.0 million of which has been drawn down, and the remaining $10.0 million of which remains available to the Company as of March 31, 2024. In addition, the Company expects to close in the second quarter of 2024 on thefour previously disclosed Conditional Commitment Letters ("CCLs") from a commercial finance lender that were executed in the second half of 2023. Together, the CCLs will provide financing of approximately $228 million to fund its 2024 facility expansions, its new greenfield facility in the Midwest, and to repay certain existing construction financing which will lower the Company’s cost of capital. The funding expected pursuant to the CCLs is subject to the completion of definitive documents and the satisfaction of customary closing conditions.

The Company believes that the additional $10.0 million of working capital from Cargill Financial, the $228 million from a commercial finance lender, the Company's current cash position, cash generated from product sales, and anticipated additional deferrals of future cash interest and principal payments under the Company's credit facilities with Cargill Financial will be adequate to fund the Company’s planned operations over the next 12 months from the issuance of these Unaudited Condensed Consolidated Financial Statements.

The Company also believes additional cash can be secured through other debt or equity financings, if necessary. However, there can be no assurance that equity or debt financing will be available to the Company should it need it or, if available, that the terms will be satisfactory to the Company and not dilutive to existing shareholders. The

Company's failure to raise capital as and when needed could have significant negative consequences for its business, financial condition and results of consolidated operations.

Recently Adopted Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for certain financial instruments with liability and equity characteristics, including convertible instruments and contracts on an entity’s own equity. The standard reduces the number of models used to account for convertible instruments, removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and requires the if-converted method for calculation of diluted earnings per share for all convertible instruments. The Company adopted this guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company's Unaudited Condensed Consolidated Financial Statements.

.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), which requires disclosure of specific categories and disaggregation of information in the rate reconciliation table. The ASU also requires disclosure of disaggregated information related to income taxes paid, income or loss from continuing operations before income tax expense or benefit, and income tax expense or benefit from continuing operations. The standard is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2024. Early adoption is permitted and the amendments should be applied on a prospective basis. The Company is currently evaluating the impact of this standard on its Unaudited Condensed Consolidated Financial Statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The standard is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of this standard on its Unaudited Condensed Consolidated Financial Statements.

  1. Inventory

Inventories consisted of the following:

March 31,December 31,
20242023
(in thousands)
Raw materials$2,382$1,843
Production3,4803,010
Finished goods74110
Inventory allowance(976)(753)
Total inventory, net$4,960$4,210
  1. Property and Equipment

Property and equipment, net consisted of the following:

March 31,December 31,
20242023
(in thousands)
Machinery, equipment, and vehicles$56,194$44,169
Land19,25319,253
Buildings and leasehold improvements86,04466,754
Construction-in-progress198,290196,324
Less: Accumulated depreciation(15,669)(13,334)
Property and equipment, net$344,112$313,166

Depreciation expense related to property and equipment was$2.3 million and $1.8 million for thethree months ended March 31, 2024 and 2023, respectively.

  1. Accrued Liabilities

Accrued liabilities consisted of the following:

March 31,December 31,
20242023
(in thousands)
Interest$11,866$9,786
Construction3,8602,995
Payroll1,6792,596
Production731690
Professional services456411
Other722726
Total accrued liabilities$19,314$17,204
  1. Debt

Debt consisted of the following:

March 31,December 31,
20242023
(in thousands)
Senior Facility$317,565$269,395
Subordinated Facility49,65248,132
Unamortized deferred financing costs(37,442)(39,542)
Total debt$329,775$277,985

Agreements with Cargill Financial

On September 3, 2021, Local Bounti Operating Company LLC and certain subsidiaries entered into (a) a credit agreement (the "Senior Credit Agreement") with Cargill Financial Services International, Inc. ("Cargill Financial") for an up to $150.0 million multiple-advance term loan (the "Senior Facility") and (b) a subordinated credit agreement (the "Subordinated Credit Agreement" and, together with the Senior Credit Agreement, the "Original Credit Agreements") with Cargill Financial for an up to $50.0 million multiple-advance term loan (the "Subordinated Facility" and, together with the Senior Facility, the "Facilities").

As previously disclosed in the Company's Annual Financial Statements, Local Bounti Operating Company LLC and certain subsidiaries entered into with Cargill Financial a First Amendment, a Second Amendment, a Third Amendment, Fourth Amendment, a Fifth Amendment, a Sixth Amendment, and a Seventh Amendment to the Original Credit Agreements.

In the first quarter of 2024, Local Bounti Operating Company LLC, the Company, and certain subsidiaries entered into with Cargill Financial an Eighth Amendment and a Ninth Amendment to the Original Credit Agreements (as so amended, collectively referred to as the "Amended Credit Agreements"), as further described below.

Eighth Amendment to Credit Agreements

On January 23, 2024, the Company, along with certain subsidiaries of the Company, entered into an Eighth Amendment to the Original Credit Agreements (the "Eighth Amendment") with Cargill Financial to further amend the Original Credit Agreements. The Eighth Amendment allows for the payment in kind of the quarterly interest payments due and payable for the quarter ending March 31, 2024.

Ninth Amendment to Credit Agreements

On March 26, 2024, the Company, along with certain of its subsidiaries, entered into a Ninth Amendment to the Original Credit Agreements (the "Ninth Amendment") with Cargill Financial to further amend the Original Credit Agreements. The Ninth Amendment allows for the payment in kind of the quarterly interest payments due and payable for the quarters ending June 30, 2024, September 30, 2024, and December 31, 2024. The Ninth amendment also provides for up to $15.0 million in working capital for the Company, $5.0 million of which was drawn down, and the remaining $10.0 million of which remains available to the Company.

General provisions to the Amended Credit Agreements

The interest rate on the Subordinated Facility is 12.5% per annum and the interest rate on the Senior Facility is equal to SOFR plus a margin (which varies between 7.5% to 8.5% depending on the Senior Facility net leverage ratio) per annum, with accrued interest paid quarterly in arrears on the first business day of the subsequent quarter through the maturity date on September 3, 2028. Principal payments under the Senior Facility are payable quarterly, beginning April 1, 2025, based on a 10-year straight line amortization schedule, with the remaining unpaid balance under both the Senior Facility and the Subordinated Facility due on the September 3, 2028 maturity date.

In accordance with the Original Credit Agreements, the Company is required to have a debt service reserve account which is shown as restricted cash on the Consolidated Balance Sheets. The Fifth Amendment and Sixth Amendment, taken together, reduced the minimum balance to maintain in the debt service reserve account to $0 through March 31, 2025. From and after April 1, 2025, the minimum balance to maintain in the debt service reserve account will be increased totwo quarters of scheduled interest payments andtwo quarters of scheduled principal payments.

The Amended Credit Agreements also contain certain financial covenants that become measurable and effective beginning in the third quarter of 2025, including debt coverage, net leverage, and interest coverage ratios. Additional covenants and other provisions exist that may limit or affect the timing of the Company's ability, among other things, to undergo a merger or consolidation, sell certain assets, create liens, guarantee certain obligations of third parties, make certain investments or acquisitions, and declare dividends or make distributions. The Facilities are secured with a first-priority lien against substantially all of the assets of the Company and its subsidiaries, including their intellectual property. The Company was in compliance with all applicable covenants as of March 31, 2024 other than the financial covenant set forth in Section 6.8(g) of the Amended Credit Agreements, for which the Company obtained a permanent waiver from Cargill Financial for the three months ended March 31, 2024.

  1. Fair Value Measurements

The following table sets forth, by level within the fair value hierarchy, the accounting of the Company’s financial assets and liabilities at fair value on a recurring and nonrecurring basis according to the valuation techniques the Company uses to determine their fair value:

Level 1Level 2Level 3
(in thousands)
Recurring fair value measurements
Assets:
Money market funds$14,607$—$—
Liabilities:
March 2023 Cargill Warrant Liability$—$—$11,394
Level 1Level 2Level 3
(in thousands)
Recurring fair value measurements
Assets:
Money market funds$16,322$—$—
Liabilities:
March 2023 Cargill Warrant Liability$—$—$7,214

The fair value of the Company's money market funds is determined using quoted market prices in active markets for identical assets.

The fair value of the March 2023 Cargill Warrant Liability is determined using a Black-Scholes model. The following table presents changes in the Level 3 fair value measurement for the warrant liability on a recurring basis:

March 31,
2024
(in thousands)
Balance as of December 31, 2023$7,214
Fair value measurement adjustments through other income (expense)4,180
Balance as of March 31, 2024$11,394

The key inputs into the Black-Scholes model used to determine the fair value of the 2023 Cargill Warrant Liability were as follows at their measurement dates:

March 31,2024
Input
Share price$2.91
Risk-free interest rate4.21%
Volatility128%
Exercise price$6.50
Warrant life (years)4.0
Dividend yield—%

As of March 31, 2024 and December 31, 2023, the carrying value of the Company's cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses approximated their respective fair values due to their short-term maturities. Therefore, no unrealized gains or losses were recorded during the periods presented. There were no transfers of financial instruments between Level 1, Level 2, and Level 3 during the periods presented.

Common Stock Purchase Warrant Amendment

On January 23, 2024, the Company entered into an Amendment to Common Stock Purchase Warrant (the "Warrant Amendment") with Cargill Financial to amend that certain Common Stock Purchase Warrant, dated March 28, 2023, issued by the Company to Cargill Financial (the "Original Warrant" and as amended, the "Warrant") to amend the exercise price under Section 2(b) thereunder from $13.00 to $6.50 per share of common stock. The impact of the reduced exercise price was included in the mark-to-market net change in fair value of the warrant liability during the three months ended March 31, 2024.

The Original Warrant was issued by the Company to Cargill Financial to purchase up to 5,353,846 shares of common stock. Pursuant to the Warrant Amendment, the Warrant entitles Cargill Financial to purchase 5,353,846 shares of common stock at an exercise price of $6.50 per share.

  1. Stock-Based Compensation

Restricted Common Stock Awards

A summary of the restricted common stock awards ("RSAs") for thethree months ended March 31, 2024 is as follows:

Number of Shares of Restricted Common Stock AwardsAverage Grant-Date Fair Value
Unvested and outstanding at December 31, 2023135,701$23.60
Vested(52,193)$25.73
Unvested and outstanding at March 31, 202483,508$22.27

Total expense of RSAs was $0.3 million and $0.2 million for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024, the total compensation cost related to unvested RSAs not yet recognized is $0.4 million. Unvested RSA expense not yet recognized is expected to be recognized over a weighted average period of 0.8 years.

Restricted Stock Units

A summary of therestricted stock units ("RSUs") activity for the three months ended March 31, 2024 is as follows:

Number of RSUsAverage Grant-Date Fair Value
Unvested and outstanding at December 31, 2023689,837$47.43
Forfeited(72,472)$59.14
Vested(165,575)$59.94
Unvested and outstanding at March 31, 2024451,790$40.94

Total (benefit) expense of RSUs, net of amounts capitalized, was $(1.2) million and $5.8 million for the three months ended March 31, 2024 and 2023, respectively. As of March 31, 2024, the total compensation cost related to unvested RSUs not yet recognized is $4.8 million. Unvested RSU expense not yet recognized is expected to be recognized over a weighted average period of 1.9 years.

  1. Net Loss Per Share

Net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. In computing net loss per share, the Company's unvested restricted common stock and warrants are not considered participating securities. Diluted loss per common share is the same as basic loss per common share for the three months ended March 31, 2024 and 2023 because the effects of potentially dilutive items were anti-dilutive given the Company's net loss. Diluted net loss per common share represents an adjustment to basic net loss per share attributable to common stockholders giving effect to all potential common shares that were dilutive and outstanding during the period.

The following table sets forth the computation of the Company's net loss per share attributable to common stockholders:

Three Months Ended March 31,
(in thousands, except share and per share data)
20242023
Net loss$(24,050)$(23,527)
Weighted average common shares outstanding, basic and diluted8,325,9447,727,866
Net loss per common share, basic and diluted$(2.89)$(3.04)

The following table discloses the weighted-average shares outstanding of securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share as the impact would be anti-dilutive:

Three Months Ended March 31,
20242023
Restricted Stock108,553249,565
Warrants6,241,4751,125,578
  1. Commitments and Contingencies

Legal Matters

The Company has and may become party to various legal proceedings and other claims that arise in the ordinary course of business. The Company records a liability when it believes that it is probable that a loss will be incurred, and the amount of loss or range of loss can be reasonably estimated. Management is currently not aware of any matters that it expects will have a material adverse effect on the financial position, results of operations, or cash flows of the Company.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.